FAQ/Help |
Calendar |
Search |
Today's Posts |
09-02-2010, 03:00 PM | #1 | ||
|
|||
Magnate
|
local pd center conducting a clinical trial and might apply. potential side affects look unappealing.
|
||
Reply With Quote |
09-02-2010, 07:40 PM | #2 | |||
|
||||
Senior Member
|
I tried it and found it made no difference in how I felt. I didn't have any problems with the patch crystalizing. But if/when it comes back on the market, I won't bother with it.
Jean
__________________
Jean B This isn't the life I wished for, but it is the life I have. So I'm doing my best. |
|||
Reply With Quote |
09-03-2010, 07:41 AM | #3 | ||
|
|||
Magnate
|
thanks, got more info after i posted.
the study is for 21 weeks, i could get the placebo. i would stay on my current meds + patch and keep a diary. no reimbursement for travel/time. no free meds or discount after the study is over. since i'm ok with current meds and could possibly get the placebo, not worth the trouble. call me selfish.. |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro® (Rotigotine) | Parkinson's Disease | |||
Rotigotine Skin Patch May Ease Restless Legs Symptoms | Parkinson's Disease | |||
NEWS: UCB Announces The U.S. Launch Of Neupro (Rotigotine Transdermal System) | Parkinson's Disease | |||
Rotigotine As Levodopa Adjunct Is Effective In Advanced Parkinson's Disease | Parkinson's Disease | |||
Rotigotine transdermal patch appears safe | Parkinson's Disease |